Shanghai Pharmaceuticals Holding Co (SHSE:601607) Long-Term Debt : ¥6,621 Mil (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Long-Term Debt?

Shanghai Pharmaceuticals Holding Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥6,621 Mil.

Shanghai Pharmaceuticals Holding Co's quarterly Long-Term Debt declined from Sep. 2023 (¥7,488 Mil) to Dec. 2023 (¥5,786 Mil) but then increased from Dec. 2023 (¥5,786 Mil) to Mar. 2024 (¥6,621 Mil).

Shanghai Pharmaceuticals Holding Co's annual Long-Term Debt declined from Dec. 2021 (¥7,158 Mil) to Dec. 2022 (¥6,260 Mil) and declined from Dec. 2022 (¥6,260 Mil) to Dec. 2023 (¥5,786 Mil).

Shanghai Pharmaceuticals Holding Co Long-Term Debt Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Long-Term Debt Chart

Shanghai Pharmaceuticals Holding Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

9,134.22

1,184.08

7,157.75

6,259.80

5,786.16

Shanghai Pharmaceuticals Holding Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															8,596.14	6,869.96	7,487.61	5,786.16	6,620.98

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Shanghai Pharmaceuticals Holding Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

SHPMY:USA SHPMF:USA 02607:Hong Kong S1R:Germany

Address

No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020

Website

https://www.sphchina.com

Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.

Executives

Ren Jian	senior management
Liu Yan Jun	senior management
Hu Feng Xiang	Director
Zuo Min	Director
Guo Jun Yu	senior management
Han Min	senior management
Lou Ding Bo	Director
Chen Xin	Supervisors
Shu Chang	senior management
Li Yong Zhong	senior management
Jiang Yuan Ying	senior management
Xu Guo Xiong	Director
Shen Bo	senior management
Ge Jian Qiu	senior management

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Headlines

No Headlines